| Literature DB >> 25527710 |
Christel Vérollet1, Shanti Souriant1, Emilie Bonnaud1, Paul Jolicoeur2, Brigitte Raynaud-Messina1, Cassandre Kinnaer1, Isabelle Fourquaux3, Andrea Imle4, Serge Benichou5, Oliver T Fackler4, Renaud Poincloux1, Isabelle Maridonneau-Parini1.
Abstract
Macrophages are motile leukocytes, targeted by HIV-1, thought to play a critical role in host dissemination of the virus. However, whether infection impacts their migration capacity remains unknown. We show that 2-dimensional migration and the 3-dimensional (3D) amoeboid migration mode of HIV-1-infected human monocyte-derived macrophages were inhibited, whereas the 3D mesenchymal migration was enhanced. The viral protein Nef was necessary and sufficient for all HIV-1-mediated effects on migration. In Nef transgenic mice, tissue infiltration of macrophages was increased in a tumor model and in several tissues at steady state, suggesting a dominant role for mesenchymal migration in vivo. The mesenchymal motility involves matrix proteolysis and podosomes, cell structures constitutive of monocyte-derived cells. Focusing on the mechanisms used by HIV-1 Nef to control the mesenchymal migration, we show that the stability, size, and proteolytic function of podosomes are increased via the phagocyte-specific kinase Hck and Wiskott-Aldrich syndrome protein (WASP), 2 major regulators of podosomes. In conclusion, HIV-1 reprograms macrophage migration, which likely explains macrophage accumulation in several patient tissues, which is a key step for virus spreading and pathogenesis. Moreover, Nef points out podosomes and the Hck/WASP signaling pathway as good candidates to control tissue infiltration of macrophages, a detrimental phenomenon in several diseases.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25527710 DOI: 10.1182/blood-2014-08-596775
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113